Smith Mark Douglas
- SEC CIK
- 0001756253
In the past year, 1 open-market sale filing worth $266.7K and no purchases.
Current role at each company
- JAZZ Jazz Pharmaceuticals plcDirectoras of Sep 2, 2026
- PHR Phreesia, Inc.Directoras of Jun 26, 2026
- TDOC Teladoc Health, Inc.Directoras of May 21, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $266.7K
- 1 filing
- Net
- −$266.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Smith Mark Douglas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JAZZ Jazz Pharmaceuticals plc
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Smith Mark DouglasDirector | SSale | −1.16K | $230.55 | −$266.7K | −10.7%9.68K after | 10b5-1 |
| Dec 6, 2023 (view filing) | Dec 4 | 2 days | Smith Mark DouglasDirector | SSale | −417 | $119.27 | −$49.7K | −5.7%6.89K after | |
| Aug 15, 2023 (view filing) | Aug 14 | 1 day | Smith Mark DouglasDirector | SSale | −1.24K | $138.16 | −$171.5K | −14.5%7.30K after | |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Smith Mark DouglasDirector | SSale | −420 | $154.68 | −$65.0K | −7.1%5.47K after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Smith Mark DouglasDirector | SSale | −1.09K | $152.32 | −$165.9K | −15.6%5.89K after | |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Smith Mark DouglasDirector | SSale | −417 | $121.30 | −$50.6K | −8.6%4.42K after |
PHR Phreesia, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 (view filing) | Jul 2 | 1 day | Smith Mark DouglasDirector | SSale | −7.00K | $29.00 | −$203.0K | −15.8%37.4K after | 10b5-1 |
| Jul 22, 2024 (view filing) | Jul 18 | 4 days | Smith Mark DouglasDirector | SSale | −7.00K | $25.00 | −$175.0K | −18.6%30.7K after | 10b5-1 |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Smith Mark DouglasDirector | SSale | −7.00K | $30.77 | −$215.4K | −30.3%16.1K after | 2 lots10b5-1 |
TDOC Teladoc Health, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 (view filing) | Aug 15 | 4 days | Smith Mark DouglasDirector | PPurchase | +4.00K | $7.08 | +$28.3K | +91.8%8.36K after |